Friday 6 November 2026 Export ABT’s income statement to Excel — free account

Abbott Laboratories

ABT Healthcare Medical Devices

Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024.

Revenue: +14.5%
EPS: −43.6%
Free cash flow: +28.9%
Total debt: +142.7%

Quarter to September 2026, against a year earlier

110.29 3.31 −2.91%

Follow ABT

Alert me

Market cap: $196.6B
P/E: 42.3×
Fwd P/E: 35.1×
Dividend yield: 2.22%
F-score: 5/9
Altman Z: 5.61
Beneish M: −2.50
Dividend safety: 62/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Abbott Laboratories (ABT) Debt to equity

Alert me on Debt to equity

Abbott Laboratories's debt to equity at the end of the quarter to 30 June 2026 was 0.6×, up 0.4× from fiscal 2025 (0.2×). Over the past ten years it has ranged from 0.2× (fiscal 2025) to 1.0× (fiscal 2016) — the current reading is the lowest in ten years. That is above the Medical Devices industry median of 0.0× and above the Healthcare sector median of 0.0×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/ABT/debt-to-equity" width="100%" height="360" style="border:0" loading="lazy" title="Abbott Laboratories debt to equity, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/ABT/metrics/debt-to-equity">Abbott Laboratories (ABT) debt to equity — stockrow.com</a></p>

Period	Debt to equity	Change
FY2025	0.2×	(16.92%)
FY2024	0.3×	(22.00%)
FY2023	0.4×	(16.81%)
FY2022	0.5×	(9.30%)
FY2021	0.5×	(10.77%)
FY2020	0.6×	(2.01%)
FY2019	0.6×	(9.09%)
FY2018	0.6×	(29.27%)
FY2017	0.9×	(10.73%)
FY2016	1.0×	262.53%

Period	Debt to equity	Change
Jun 2026	0.6×	(2.48%)
Mar 2026	0.6×	163.67%
Dec 2025	0.2×	(2.93%)
Sep 2025	0.3×	(4.54%)
42 more quarters	Free account

Against its own ten years

Low 0.2× High 1.0×

Ten-year median 0.5×

Current reading's percentile 9

Company	Debt to equity
EW Edwards Lifesciences Corporation compare	0.1×
STE STERIS plc compare	0.3×
BSX Boston Scientific Corporation compare	0.5×
DXCM DexCom, Inc. compare	0.5×
MDT Medtronic PLC compare	0.6×
PHG Koninklijke Philips N.V. compare	0.6×
ABT Abbott Laboratories	0.6×
SYK Stryker Corporation compare	0.6×
GEHC GE HealthCare Technologies Inc. compare	1.0×
Medical Devices industry median	0.0×
Healthcare sector median	0.0×
Market median	0.1×

What Debt to equity is

Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.

(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)

The full definition of Debt to equity →

Abbott Laboratories (ABT) Debt to equity

Debt to equity, annual

Annual newest first

Quarterly newest first

Against its own ten years

Debt to equity against peers

What Debt to equity is

More on ABT

Debt to equity, annual

Annual newest first

Quarterly newest first

Against its own ten years

Debt to equity against peers

What Debt to equity is

More on ABT

Stockrow Weekly